1)Riechelmann RP, et al : Futile medication use in terminally ill cancer patients. Support Care Cancer 17(6) : 745-748, 2009. PMID 19030900
2)Yale SH, et al : Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome ; associated illness and prior corticosteroid therapy. Mayo Clin Proc 71(1) : 5-13, 1996. PMID 8538233
3)Limper AH, et al : An official American Thoracic Society statement ; treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 183(1) : 96-128, 2011. PMID 21193785
4) 厚生労働省:医療上の必要性の高い未承認薬・適応外薬検討会議 公知申請への該当性に係る報告書(案)—スルファメトキサゾール・トリメトプリム ニューモシスチス肺炎の予防及び治療.厚生労働省,2010. http://www.mhlw.go.jp/stf/shingi/2r9852000001z008-att/2r9852000001z06v.pdf
5)西垣豊,他:肺癌患者におけるニューモシスチス肺炎の臨床的検討.肺癌 49(3) : 241-247, 2009.
6)Manzoli L, et al : Generic versus brand-name drugs used in cardiovascular diseases. Eur J Epidemiol 31(4) : 351-368, 2016. PMID 26620809
7)Rosen LS, et al : Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : a randomized, Phase III, double-blind, placebo-controlled trial. Cancer 100(12) : 2613-2621, 2004. PMID 15197804
8)Henry DH, et al : Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer(excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29(9) : 1125-1132, 2011. PMID 21343556
9)Tscheikuna J, et al : Tranexamic acid in patients with hemoptysis. J Med Assoc Thai 85(4) : 399-404, 2002. PMID 12118485
ブロッカーとの比較).そもそも“ナゾ処方”とは?—不適切処方をしない/放置しないための8箇条.総合診療26(6):444-517, 2016.
11)北和也(編):“賢い処方”と“ナゾ処方”.総合診療26(6):444-517, 2016.